<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">MRP</journal-id><journal-title-group><journal-title>Medical Research and Practice</journal-title></journal-title-group><issn>2993-9690</issn><eissn>2993-9704</eissn><publisher><publisher-name>Art and Design</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.61369/mrp.6115</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>艾司氯胺酮对苏醒期躁动和谵妄影响的meta分析</title><url>https://artdesignp.com/journal/MRP/2/4/10.61369/mrp.6115</url><author>刘姝然,方芷萱,盖凡铮,王娜</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>2</volume><issue>4</issue><history><date date-type="pub"><published-time>2024-04-20</published-time></date></history><abstract>目的 对艾司氯胺酮对苏醒期躁动和谵妄影响进行meta分析。方 法 检索英文数据库 2023年11月14日前发表的关于艾司氯胺酮应用和苏醒期躁动和谵妄关系的文献，计算效应指标OR值和95%CI。用漏斗图和egger法评估发表偏倚。用TSA9.0进行试验序贯分析。结 果 META分析结果显示接受艾司氯胺酮的患者术后躁动的发生率显著降低（OR = 0.2, 95%CI [0.11; 0.37], I2 = 0%）术后谵妄的发生率显著降低（OR = 0.32, 95% CI [0.71; 0.60], I2 =0%）。且试验序贯分析进一步肯定了meta分析的结果。结论无论剂量、使用的给药模式或手术类型如何，围术期输注艾司氯胺酮可以降低术后躁动和谵妄的发生率。</abstract><keywords>艾司氯胺酮,术后躁动,术后谵妄,Meta,试验序贯分析</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1]Constantinescu DS, Costello JP 2nd, Yakkanti RR, et al. Varying Complication Rates and Increased Costs in Technology-Assisted Total Hip Arthroplasty Versus Conventional Instrumentation in 1,372,300 Primary Total Hips. J Arthroplasty. 2023 : S0883-5403(23)01211-1 [pii].[2]Yu D, Chai W, Sun X, Yao L. Emergence agitation in adults: risk factors in 2,000 patients. Can J Anaesth. 2010. 57(9): 843-8.[3]Dahmani S, Stany I, Brasher C, et al. Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth. 2010. 104(2): 216-23.[4]Jin Z, Hu J, Ma D. Postoperative delirium: perioperative assessment, risk reduction, and management. Br J Anaesth. 2020. 125(4): 492-504.[5]Evered L, Silbert B, Knopman DS, et al. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 2018.121(5): 1005-1012.[6]Liu W, Sun R, Gao X, Wang S. Effects of preoperative nasal spray esketamine on separation anxiety and emergence agitation in pediatric strabismus surgery: Arandomized clinical trial. Medicine (Baltimore). 2022. 101(51): e32280.[7]He J, Zhang L, Tao T, et al. Nalbuphine reduces the incidence of emergence agitation in children undergoing Adenotonsillectomy: A prospective, randomized, doubleblind,multicenter study. J Clin Anesth. 2023. 85: 111044.[8]Himmelseher S, Pfenninger E, Kochs E, Auchter M. S(+)-ketamine up-regulates neuronal regeneration associated proteins following glutamate injury in cultured rat hippocampal neurons. J Neurosurg Anesthesiol. 2000. 12(2): 84-94.[9]H&amp;ouml;flich A, Kraus C, Pfeiffer RM, et al. Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial. Transl Psychiatry. 2021. 11(1): 200.[10]Nummela AJ, Laaksonen LT, Laitio TT, et al. Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy. Eur J Anaesthesiol. 2022. 39(6): 521-532.[11] 杨杰文，曹浩林．不同麻醉方式在降低髋关节置换术患者苏醒期躁动发生率中的效果．透析与人工器官．2023. 34(04): 65-68.[12] 何烨．非体外循环冠状动脉搭桥术后谵妄与糖化血红蛋白及术后血糖的相关性研究 ,2022.[13]Hu F, Wang Q, Yang Y, Liu Y. The Impact of Esketamine Combined with Dexmedetomidine on Laparoscopic Gallbladder Surgery: A Randomized Controlled Trial. Altern Ther Health Med. 2024. 30(2): 25-29.[14]Wang J, Huang J, Yang S, et al. Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study. Drug Des Devel Ther. 2019. 13: 4135-4144.[15]Wen Y, Mao M, Wang X, et al. Efficacy and safety of perioperative application of esketamine on postpartum depression: A meta-analysis of randomized controlled studies.Psychiatry Res. 2024. 333: 115765.[16]Huang X, Lin F, Chen Q, Hu X. Safety and efficacy of the combination of esketamine and propofol in procedural sedation/analgesia: a systematic review and metaanalysis.Minerva Anestesiol. 2023. 89(7-8): 680-689.[17]Wang J, Wang Y, Xu X, Peng S, Xu F, Liu P. Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy. Med Sci Monit. 2020. 26: e922028.[18]Chen H, Ding X, Xiang G, et al. Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis. BMC Anesthesiol. 2023. 23(1): 245.[19] 田春林，涂青梅，陈好亮，田刚．艾司氯胺酮的临床应用进展．河北医药．2024. 46(08): 1234-1238.[20] 王秀红．亚麻醉剂量艾司氯胺酮调控小胶质细胞TLR4/NF-&amp;kappa;B 通路对术后认知影响及机制研究［D］．2021.[21] 杨春，刘寒玉，刘存明．艾司氯胺酮的临床应用进展［J］．临床麻醉学杂志,2023,39(4):414-417.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
